DEUCRAVACITINIB vs DEXKETOPROFEN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DEUCRAVACITINIB vs DEXKETOPROFEN: Safety Overview
| Metric | DEUCRAVACITINIB | DEXKETOPROFEN |
|---|---|---|
| Total FAERS Reports | 2,386 | 469 |
| Deaths Reported | 36 | 39 |
| Death Rate | 1.5% | 8.3% |
| Hospitalizations | 121 | 233 |
| Average Patient Age | 56.8 yrs | 49.2 yrs |
| % Female Patients | 63.8% | 66.2% |
| FDA Approval Date | Sep 9, 2022 | N/A |
| Manufacturer | E.R. Squibb & Sons, L.L.C. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |